Anqitan is a prescription drug for the treatment of dysfunction caused by progesterone deficiency. In fact, progesterone is an important hormone, which also plays a key role in human regulation.
Xuenuotong is a drug with indications of assisted reproductive technology developed by Merck Serono Company. It is an important method in ART technology to cause luteal insufficiency caused by controlled ovarian hyperstimulation, which can make up for the lack of progesterone in pregnant women, thus promoting endometrial development, making the uterus conducive to fetal growth, and having the functions of protecting and preventing pregnancy. At present, progesterone supplementation is widely used in assisted reproductive technology to improve luteal insufficiency. In addition, studies have shown that for patients with threatened abortion and habitual abortion caused by insufficient progesterone secretion in the body, supplementing natural progesterone can ensure the normal function of endometrium, inhibit uterine contraction, promote the growth and development of embryos, and ensure the smooth growth and development of fetuses in the uterus, which is conducive to the continuation of pregnancy.